Navigation Links
Medication effective for acute liver failure in early stages of disease
Date:10/7/2009

DALLAS Oct. 8, 2009 The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs, UT Southwestern Medical Center researchers and their colleagues at 21 other institutions have found.

Acute liver failure occurs when cells in the liver die quickly, resulting in toxins being released into the bloodstream and brain. Patients often end up in a hepatic coma as a result of toxins not being cleared by the failing liver. Known causes of acute liver failure include autoimmune hepatitis, drug-induced liver injury, hepatitis A and B, and acetaminophen poisoning.

In a study published in the September issue of Gastroenterology, researchers found that acute liver failure patients in early stages of hepatic comas, when treated with the medicine N-acetylcysteine (NAC), were nearly 2.5 times more likely to survive than those treated only with a placebo.

"NAC is safe, easy to administer, doesn't require intensive care and can be given in community hospitals," said Dr. William M. Lee, professor of internal medicine at UT Southwestern and lead author of the study. "NAC is an excellent treatment for non-acetaminophen acute liver failure if the disease is caught early."

Acute liver failure affects about 2,000 people annually in the U.S., and 50 percent of those cases are caused by acetaminophen poisoning. Until this study, liver transplantation was the only treatment if the failure was from non-acetaminophen causes.

To test NAC's use in non-acetaminophen cases, researchers at 22 sites randomly assigned non-acetaminophen acute liver failure patients by the level of their coma, with those with mild to moderate coma in one group, and patients with more severe coma in the other group. Beginning in 1999 and continuing for eight years, 173 patients received either NAC or a placebo for 72 hours. Doctors recorded patient survival three weeks after they were placed on treatment.

Researchers found that 52 percent of acute liver failure patients in mild to moderate comas survived when treated with NAC, compared to just 30 percent of those treated with only a placebo. In patients experiencing more severe coma, treatment with NAC did not result in a significant difference in survival rates.

"That makes sense because patients with advanced comas typically die or get a transplant within a few days," said Dr. Lee, principal investigator of the Acute Liver Failure Study Group, a national consortium of liver centers formed in 1997 to increase research into the rare disease.

"This study establishes NAC as a treatment for non-acetaminophen acute liver failure patients in mild to moderate coma and provides the first glimmer of hope that something can help these direly ill patients," Dr. Lee said.

He said he will continue to study NAC as a therapy for acute liver failure not caused by acetaminophen poisoning to determine optimal dosing and duration.


'/>"/>

Contact: LaKisha Ladson
lakisha.ladson@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. Many Kids Suffer Medication Side Effects: Study
2. New Source of Information on Eczema Medications
3. Diabetes Medications Dont Lower Inflammation
4. Patients Get Free Text or Email Prescription Medication Reminders From FreeRxReminder.com
5. Medications That Lower Breast Cancer Risk Carry Other Dangers
6. Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate
7. Center for Technology and Aging Releases Guidelines for $500,000 Medication Optimization Diffusion Grants Program
8. CVS Caremark Data Finds More than 50 Percent of Adults 45-years and Younger are not Adherent to Cholesterol Lowering Medications
9. Medication Review May Help With Heart Failure
10. Misuse of Pain Medication Draws Heightened Concerns
11. Digitek Medication Recalled Due to Risk of Digitalis Toxicity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medication effective for acute liver failure in early stages of disease
(Date:2/20/2017)... , ... February 20, 2017 , ... ... welcomes you to stop by for a visit this week at HIMSS 2017 ... and executives from around the globe. Sensogram will be featured in the conference’s ...
(Date:2/20/2017)... ... February 20, 2017 , ... Chuck E. Cheese’s® and Center for Autism ... event at Chuck E. Cheese’s locations throughout New England, New York and New Jersey ... to experience the fun of visiting Chuck E. Cheese’s in a sensory-friendly environment. ...
(Date:2/19/2017)... ... ... a set of 30 glitch distortion logo reveals made exclusively for Final Cut Pro ... reveal in just a few clicks of a mouse. Customizable glitch style effects give Final ... presets to add a uniquely animated logo to any photos or videos. Its never been ...
(Date:2/18/2017)... ... 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing ... Ken was impressed with the safety and reliability of the Stannah Stairlift as ... show. This endorsement by Ken Matthews can be heard on News Radio WHP ...
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is a comprehensive ... Dr. Brian Seese leads the practice as a skilled and highly credentialed dentist who ... by Seese serves patients of all ages with excellence in general, restorative, and ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 2017  Henry Schein, Inc. (Nasdaq: HSIC), the ... and services to office-based dental, animal health, ... has entered into an agreement to acquire ... U.S. distributor of anesthesia and surgical supplies ... SAS offers controlled and non-controlled pharmaceuticals, as ...
(Date:2/20/2017)... NEW YORK , Feb. 20, 2017  This report analyzes ... US$ Million. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... World. Read the full report: http://www.reportlinker.com/p04707127-summary/view-report.html ... the period 2015 through 2022. Also, a six-year historic analysis ...
(Date:2/20/2017)... , Feb. 20, 2017 Research and ... Tourism Market: Insights, Opportunity, Analysis, Market Shares & Forecast 2017 - ... ... to reach nearly USD 2 Billion by the year end of ... 2022. Market growth can be attributed to factors ...
Breaking Medicine Technology: